Tan Y - Search Results

1

Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.

Jiang B, Zhu H, Tang L, Gao T, Zhou Y, Gong F, Tan Y, Xie L, Wu X, Li Y. Jiang B, et al. Among authors: tan y. Anticancer Agents Med Chem. 2022;22(9):1723-1734. doi: 10.2174/1871520621666210412103849. Anticancer Agents Med Chem. 2022. PMID: 33845750

2

Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer.

Li Y, Jiang B, Zhu H, Qu X, Zhao L, Tan Y, Jiang Y, Liao M, Wu X. Li Y, et al. Among authors: tan y. Tumour Biol. 2017 Jun;39(6):1010428317705790. doi: 10.1177/1010428317705790. Tumour Biol. 2017. PMID: 28635401 Free article.

3

Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2.

Jiang B, Li Y, Qu X, Zhu H, Tan Y, Fan Q, Jiang Y, Liao M, Wu X. Jiang B, et al. Among authors: tan y. Int J Mol Med. 2018 Nov;42(5):2801-2810. doi: 10.3892/ijmm.2018.3812. Epub 2018 Aug 7. Int J Mol Med. 2018. PMID: 30106089

4

MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer.

Yang C, Zhu H, Tan Y, Zhu R, Wu X, Li Y, Wang C. Yang C, et al. Among authors: tan y. Curr Cancer Drug Targets. 2021;21(10):860-869. doi: 10.2174/1568009621666210618164300. Curr Cancer Drug Targets. 2021. PMID: 34148540

5

Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining.

Wang P, Xiao WS, Li YH, Wu XP, Zhu HB, Tan YR. Wang P, et al. Dis Markers. 2021 Dec 2;2021:1769635. doi: 10.1155/2021/1769635. eCollection 2021. Dis Markers. 2021. PMID: 34900024 Free PMC article.

6

Circ0038632 modulates MiR-186/DNMT3A axis to promote proliferation and metastasis in osteosarcoma.

Tan X, Zeng C, Li H, Tan Y, Zhu H. Tan X, et al. Among authors: tan y. Front Oncol. 2022 Aug 18;12:939994. doi: 10.3389/fonc.2022.939994. eCollection 2022. Front Oncol. 2022. PMID: 36059626 Free PMC article.

7

miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway.

Tan Y, Li Y, Zhu H, Wu X, Mei K, Li P, Yang Q. Tan Y, et al. J Oncol. 2022 Sep 17;2022:5456016. doi: 10.1155/2022/5456016. eCollection 2022. J Oncol. 2022. PMID: 36164345 Free PMC article.

8

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer.

Qi X, Wan Z, Jiang B, Ouyang Y, Feng W, Zhu H, Tan Y, He R, Xie L, Li Y. Qi X, et al. Among authors: tan y. Front Immunol. 2022 Nov 24;13:1038225. doi: 10.3389/fimmu.2022.1038225. eCollection 2022. Front Immunol. 2022. PMID: 36505465 Free PMC article. Review.

9

Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression.

Tan YR, Jiang BH, Feng WJ, He ZL, Jiang YL, Xun Y, Wu XP, Li YH, Zhu HB. Tan YR, et al. Aging (Albany NY). 2024 Jan 19;16(2):1796-1807. doi: 10.18632/aging.205460. Epub 2024 Jan 19. Aging (Albany NY). 2024. PMID: 38244593 Free PMC article.

10

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.

Ou X, Tan Y, Xie J, Yuan J, Deng X, Shao R, Song C, Cao X, Xie X, He R, Li Y, Tang H. Ou X, et al. Among authors: tan y. Drug Resist Updat. 2024 Mar;73:101063. doi: 10.1016/j.drup.2024.101063. Epub 2024 Feb 1. Drug Resist Updat. 2024. PMID: 38335844 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,120 results

Search Page

Filters